Differential regulation by AT 1 and AT 2 receptors of angiotensin II-stimulated cyclic GMP production in rat uterine artery and aorta

British Journal of Pharmacology

Volumn 141, Issue 6, 2004, Pages 1024-1031

  Hannan, Ruth E ^a   Gaspari, Tracy A ^a   Davis, Elizabeth A ^a   Widdop, Robert E ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Angiotensin II; AT 1 receptor; AT 2 receptor; Bradykinin; Cyclic GMP; Nitric oxide; Rat aorta; Rat uterine artery; Signal transduction

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BRADYKININ; BRADYKININ B2 RECEPTOR ANTAGONIST; CYCLIC GMP; ICATIBANT; LOSARTAN; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; RECEPTOR SUBTYPE;

ANIMAL TISSUE; AORTA; ARTICLE; BLOOD VESSEL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; UTERINE ARTERY;

ANGIOTENSIN II; ANIMALS; AORTA; ARTERIES; CYCLIC GMP; FEMALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; UTERUS; VASOCONSTRICTOR AGENTS;

EID: 1942472477     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705694     Document Type: Article

References (42)

1. BARBER, M.N., SAMPEY, D.B. & WIDDOP, R.E. (1999). AT(2) receptor stimulation enhances antihypertensive effect of AT(1) receptor antagonist in hypertensive rats. Hypertension, 34, 1112-1116.
2. BARTUNEK, J., WEINBERG, E.O., TAJIMA, M., ROHRBACH, S. & LORELL, B.H. (1999). Angiotensin II type 2 receptor blockade amplifies the early signals of cardiac growth response to angiotensin II in hypertrophied hearts. Circulation, 99, 22-25.
3. BRECHLER, V., JONES, P.W., LEVENS, N.R., DE GASPARO, M. & BOTTARI, S.P. (1993). Agonistic and antagonistic properties of angiotensin analogs at the AT2 receptor in PC12W cells. Regul. Pept., 44, 207-213.
4. BURRELL, J.H. & LUMBERS, E.R. (1997). Angiotensin receptor subtypes in the uterine artery during ovine pregnancy. Eur. J. Pharmacol., 330, 257-267.
5. CAPUTO, L., BENESSIANO, J., BOULANGER, C.M. & LEVY, B.I. (1995). Angiotensin II increases cGMP content via endothelial angiotensin II AT1 subtype receptors in the rat carotid artery. Arteriosc. Thromb. Vasc. Biol., 15, 1646-1651.
6. COX, B.E., ROSENFELD, C.R., KALINYAK, J.E., MAGNESS, R.R. & SHAUL, P.W. (1996a). Tissue specific expression of vascular smooth muscle angiotensin II receptor subtypes during ovine pregnancy. Am. J. Physiol., 271, H212-H221.
7. COX, B.E., WORD, R.A. & ROSENFELD, C.R. (1996b). Angiotensin II receptor characteristics and subtype expression in uterine arteries and myometrium during pregnancy. J. Clin. Endocrinol. Metab., 81, 49-58.
8. DE GASPARO, M. & SIRAGY, H.M. (1999). The AT2 receptor: fact, fancy and fantasy. Regul. Pept., 81, 11-24.
9. DIMITROPOULOU, C., WHITE, R.E., FUCHS, L., ZHANG, H., CATRAVAS, J.D. & CARRIER, G.O. (2001). Angiotensin II relaxes microvessels via the AT(2) receptor and Ca(2+)-activated K(+) (BK(Ca)) channels. Hypertension, 37, 301-307.
10. GALLINAT, S., BUSCHE, S., RAIZADA, M.K. & SUMNERS, C. (2000). The angiotensin II type 2 receptor: an enigma with multiple variations. Am. J. Physiol., 278, E357-E374.
11. GOHLKE, P., LAMBERTY, V., KUWER, I., BARTENBACH, S., SCHNELL, A., LINZ, W., SCHOLKENS, B.A., WIEMER, G. & UNGER, T. (1993). Long-term low-dose angiotensin converting enzyme inhibitor treatment increases vascular cyclic guanosine 3′,5′-monophosphate. Hypertension, 22, 682-687.
12. GOHLKE, P., PEES, C. & UNGER, T. (1998). AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. Hypertension, 31, 349-355.
13. GRIENDLING, K.K., LASSEGUE, B. & ALEXANDER, R.W. (1996). Angiotensin receptors and their therapeutic implications. Annu. Rev. Pharmacol. Toxicol., 36, 281-306.
14. HANNAN, R.E., DAVIS, E.A. & WIDDOP, R.E. (2003). Functional role of angiotensin II AT2 receptor in modulation of AT1 receptor-mediated contraction in rat uterine artery: involvement of bradykinin and nitric oxide. Br. J. Pharmacol., 140, 987-995.
15. HECKER, M., BARA, A.T. & BUSSE, R. (1993). Relaxation of isolated coronary arteries by angiotensin-converting enzyme inhibitors: role of endothelium-derived kinins. J. Vasc. Res., 30, 257-262.
16. HOLZMANN, S., KUKOVETZ, W.R., WINDISCHHOFER, W., PASCHKE, E. & GRAIER, W.F. (1994). Pharmacologic differentiation between endothelium-dependent relaxations sensitive and resistant to nitro-L-arginine in coronary arteries. J. Cardiovasc. Pharmacol., 23, 747-756.
17. HORIUCHI, M., AKISHITA, M. & DZAU, V.J. (1999). Recent progress in angiotensin II type 2 receptor research in the cardiovascular system. Hypertension, 33, 613-621.
18. KATADA, J. & MAJIMA, M. (2002). AT(2) receptor-dependent vasodilation is mediated by activation of vascular kinin generation under flow conditions. Br. J. Pharmacol., 136, 484-491.
19. LOPEZ, J.J., LORELL, B.H., INGELFINGER, J.R., WEINBERG, E.O., SCHUNKERT, H., DIAMANT, D. & TANG, S.S. (1994). Distribution and function of cardiac angiotensin AT1-and AT2-receptor subtypes in hypertrophied rat hearts. Am. J. Physiol., 267, H844-H852.
20. MACARI, D., BOTTARI, S., WHITEBREAD, S., DE GASPARO, M. & LEVENS, N. (1993). Renal actions of the selective angiotensin AT2 receptor ligands CGP 42112B and PD 123319 in the sodium-depleted rat. Eur. J. Pharmacol., 249, 85-93.
21. MAGNESS, R.R., ROSENFELD, C.R., HASSAN, A. & SHAUL, P.W. (1996). Endothelial vasodilator production by uterine and systemic arteries. I. Effects of ANG II on PGI 2 and NO in pregnancy. Am. J. Physiol., 270, H1914-H1923.
22. MATROUGUI, K., LOUFRANI, L., HEYMES, C., LEVY, B.I. & HENRION, D. (1999). Activation of AT(2) receptors by endogenous angiotensin II is involved in flow-induced dilation in rat resistance arteries. Hypertension, 34, 659-665.
23. MATSUBARA, H. (1998). Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ. Res., 83, 1182-1191.
24. MOMBOULI, J.V., ILLIANO, S., NAGAO, T., SCOTT-BURDEN, T. & VANHOUTTE, P.M. (1992). Potentiation of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors. Circ. Res., 71, 137-144.
25. PEES, C., UNGER, T. & GOHLKE, P. (2003). Effect of angiotensin AT2 receptor stimulation on vascular cyclic GMP production in normotensive Wistar Kyoto rats. Int. J. Biochem. Cell Biol., 35, 963-972.
26. ROSENKRANZ, A.C., HOOD, S.G., WOODS, R.L., DUSTING, G.J. & RITCHIE, R.H. (2002). Acute antihypertrophic actions of bradykinin in the rat heart: importance of cyclic GMP. Hypertension, 40, 498-503.
27. SAITO, S., HIRATA, Y., EMORI, T., IMAI, T. & MARUMO, F. (1996). Angiotensin II activates endothelial constitutive nitric oxide synthase via AT1 receptors. Hypertens. Res., 19, 201-206.
28. SEYEDI, N., XU, X., NASJLETTI, A. & HINTZE, T.H. (1995). Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation. Hypertension, 26, 164-170.
29. SIRAGY, H.M. & CAREY, R.M. (1996). The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3′,5′-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats. J. Clin. Invest., 97, 1978-1982.
30. SIRAGY, H.M. & CAREY, R.M. (1997). The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J. Clin. Invest., 100, 264-269.
31. SIRAGY, H.M. & CAREY, R.M. (1999). Protective role of the angiotensin AT2 receptor in a renal wrap hypertension model. Hypertension, 33, 1237-1242.
32. SIRAGY, H.M., DE GASPARO, M. & CAREY, R.M. (2000). Angiotensin type 2 receptor mediates valsartan-induced hypotension in conscious rats. Hypertension, 35, 1074-1077.
33. ST-LOUIS, J., SICOTTE, B., BEDARD, S. & BROCHU, M. (2001). Blockade of angiotensin receptor subtypes in arcuate uterine artery of pregnant and postpartum rats. Hypertension, 38, 1017-1023.
34. THORUP, C., KORNFELD, M., WINAVER, J.M., GOLIGORSKY, M.S. & MOORE, L.C. (1998). Angiotensin-II stimulates nitric oxide release in isolated perfused renal resistance arteries. Pflügers Arch., 435, 432-434.
35. TIMMERMANS, P.B., WONG, P.C., CHIU, A.T., HERBLIN, W.F., BENFIELD, P., CARINI, D.J., LEE, R.J., WEXLER, R.R., SAYE, J.A. & SMITH, R.D. (1993). Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol. Rev., 45, 205-251.
36. TSUTSUMI, Y., MATSUBARA, H., MASAKI, H., KURIHARA, H., MURASAWA, S., TAKAI, S., MIYAZAKI, M., NOZAWA, Y., OZONO, R., NAKAGAWA, K., MIWA, T., KAWADA, N., MORI, Y., SHIBASAKI, Y., TANAKA, Y., FUJIYAMA, S., KOYAMA, Y., FUJIYAMA, A., TAKAHASHI, H. & IWASAKA, T. (1999). Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J. Clin. Invest., 104, 925-935.
37. VISWANATHAN, M., TSUTSUMI, K., CORREA, F.M. & SAAVEDRA, J.M. (1991). Changes in expression of angiotensin receptor subtypes in the rat aorta during development. Biochem. Biophys. Res. Commun., 179, 1361-1367.
38. WIDDOP, R.E., JONES, E.S., HANNAN, R.E. & GASPARI, T.A. (2003). Angiotensin AT2 receptors: cardiovascular hope or hype? Br. J. Pharmacol., 140, 809-824.
39. WIDDOP, R.E., MATROUGUI, K., LEVY, B.I. & HENRION, D. (2002). AT2 receptor-mediated relaxation is preserved after long-term AT1 receptor blockade. Hypertension, 40, 516-520.
40. WIEMER, G., SCHOLKENS, B.A., BUSSE, R., WAGNER, A., HEITSCH, H. & LINZ, W. (1993). The functional role of angiotensin II-subtype AT2-receptors in endothelial cells and isolated ischemic rat hearts. Pharm. Pharmacol. Lett., 3, 24-27.
41. ZHAO, Y., BIERMANN, T., LUTHER, C., UNGER, T., CULMAN, J. & GOHLKE, P. (2003). Contribution of bradykinin and nitric oxide to AT2 receptor-mediated differentiation in PC12 W cells. J. Neurochem., 85, 759-767.
42. ZWART, A.S., DAVIS, E.A. & WIDDOP, R.E. (1998). Modulation of AT1 receptor-mediated contraction of rat uterine artery by AT2 receptors. Br. J. Pharmacol., 125, 1429-1436.